Literature DB >> 428228

Acceptability of a nonsurgical method to terminate very early pregnancy in comparison to vacuum aspiration.

A S Rosén, L Nystedt, M Bygdeman, V Lundström.   

Abstract

Seventy-seven patients applying for abortion during early pregnancy consented to be treated by prostaglandin vaginal suppositories or vacuum aspiration by Kahrman catheter in a random design. They also consented to participate in an acceptability study of the two procedures. Attitude and preference measures were obtained by interviewing and rating scales on three occasions: before assignment to abortion procedure, immediately after treatment, and two weeks later. The first 30 patients with complete abortion by either procedure participated in the acceptability study. Both treatments were positively evaluated but perceived to have very different characteristics. The preference for the method used for own treatment increased in both groups. Before treatment 1/3 of the patients in each group had a positive attitude to a self-administered method to induce abortion outside clinics. This proportion increased significantly after treatment but only in the group that received prostaglandin by the vaginal route.

Entities:  

Keywords:  Abortifacient Agents; Abortion, Induced; Attitude; Behavior; Biology; Comparative Studies; Developed Countries; Endocrine System; Europe; Family Planning; Fertility Control, Postconception; Northern Europe; Physiology; Prostaglandins; Psychological Factors; Research Methodology; Scandinavia; Studies; Sweden; Vacuum Aspiration; Western Europe

Mesh:

Substances:

Year:  1979        PMID: 428228     DOI: 10.1016/s0010-7824(79)80023-2

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  2 in total

1.  Political, economic and ethical aspects of use of medical abortifacients.

Authors:  P J Macrow
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

2.  Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment.

Authors:  R C Henshaw; S A Naji; I T Russell; A A Templeton
Journal:  BMJ       Date:  1993-09-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.